Identification of cytochrome P450 isoforms involved in 1-hydroxylation of pyrene

Environmental Research

Volumn 94, Issue 3, 2004, Pages 262-266

  Kim, Yong Dae ^a   Todoroki, Hidekazu ^b   Oyama, Tsunehiro ^a   Isse, Toyohi ^a   Matsumoto, Akiko ^a   Yamaguchi, Tetsunosuke ^a   Kim, Heon ^c   Uchiyama, Iwao ^d   Kawamoto, Toshihiro ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b Japan Labour Health and Welfare Organization   (Japan)

^c Chungbuk National University College of Medicine   (South Korea)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

1 Hydroxypyrene; Cytochrome P450; Metabolism; Polyaromatic Hydrocarbon; Pyrene

Indexed keywords

1 HYDROXYPYRENE; CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 1B1; CYTOCHROME P450 2A6; CYTOCHROME P450 2C8; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; CYTOCHROME P450 2E1; CYTOCHROME P450 3A4; POLYCYCLIC AROMATIC HYDROCARBON; PYRENE;

BIOMARKER; ENZYME ACTIVITY; METABOLISM;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HYDROXYLATION; IN VITRO STUDY; METABOLISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS;

ARYL HYDROCARBON HYDROXYLASES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP1A2; CYTOCHROME P-450 ENZYME SYSTEM; DNA, COMPLEMENTARY; HUMANS; HYDROXYLATION; ISOENZYMES; KINETICS; MIXED FUNCTION OXYGENASES; PYRENES;

EID: 1542381378     PISSN: 00139351     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0013-9351(03)00134-8     Document Type: Article

References (23)

1. Elovaara E. Oxidation of pyrene in human liver and lungs. Hum. Exp. Toxicol. 14:1995;821.
2. Gelboin H.V. Benzo[alpha]pyrene metabolism, activation and carcinogenesis. role and regulation of mixed-function oxidases and related enzymes Physiol. Rev. 60:1980;1107-1166.
3. Guengerich F.P. Metabolism of chemical carcinogens. Carcinogenesis. 21:2000;345-351.
4. Guengerich F.P., Shimada T. Activation of procarcinogens by human cytochrome P450 enzymes. Mutat. Res. 400:1998;201-213.
5. Hayes C.L., Spink D.C., Spink B.C., Cao J.Q., Walker N.J., Sutter T.R. 17 Beta-Estradiol hydroxylation catalyzed by human cytochrome P450 1B1. Proc. Natl. Acad. Sci. USA. 93:1996;9776-9781.
6. Jongeneelen F.J., Anzion R.B., Scheepers P.T., Bos R.P., Henderson P.T., Nijenhuis E.H., Veenstra S.J., Brouns R.M., Winkes A. 1-Hydroxypyrene in urine as a biological indicator of exposure to polycyclic aromatic hydrocarbons in several work environments. Ann. Occup. Hyg. 32:1988;35-43.
7. Kawajiri K., Fujii-Kuriyama Y. P450 and human cancer. Jpn. J. Cancer Res. 82:1991;1325-1335.
8. Kim J.H., Stansbury K.H., Walker N.J., Trush M.A., Strickland P.T., Sutter T.R. Metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-diol by human cytochrome P450 1B1. Carcinogenesis. 19:1998;1847-1853.
9. Kim H., Cho S.H., Kang J.W., Kim Y.D., Nan H.M., Lee C.H., Lee H., Kawamoto T. Urinary 1-hydroxypyrene and 2-naphthol concentrations in male Koreans. Int. Arch. Occup. Environ. Health. 74:2001;59-62.
10. Lee C.Y., Lee J.Y., Kang J.W., Kim H. Effects of genetic polymorphisms of CYP1A1, CYP2E1, GSTM1, and GSTT1 on the urinary levels of 1-hydroxypyrene and 2-naphthol in aircraft maintenance workers. Toxicol. Lett. 123:2001;115-124.
11. Luch A., Coffing S.L., Tang Y.M., Schneider A., Soballa V., Greim H., Jefcoate C.R., Seidel A., Greenlee W.F., Baird W.M., Doehmer J. Stable expression of human cytochrome P450 1B1 in V79 Chinese hamster cells and metabolically catalyzed DNA adduct formation of dibenzo[a,l]pyrene. Chem. Res. Toxicol. 11:1998;686-695.
12. Merlo F., Andreassen A., Weston A., Pan C.F., Haugen A., Valerio F., Reggiardo G., Fontana V., Garte S., Puntoni R., Abbondandolo A. Urinary excretion of 1-hydroxypyrene as a marker for exposure to urban air levels of polycyclic aromatic hydrocarbons. Cancer Epidemiol. Biomarkers Prev. 7:1998;147-155.
13. Nan H.M., Kim H., Lim H.S., Choi J.K., Kawamoto T., Kang J.W., Lee C.H., Kim Y.D., Kwon E.H. Effects of occupation, lifestyle and genetic polymorphisms of CYP1A1, CYP2E1, GSTM1 and GSTT1 on urinary 1-hydroxypyrene and 2-naphthol concentrations. Carcinogenesis. 22:2001;787-793.
14. Nerurkar P.V., Okinaka L., Aoki C., Seifried A., Lum-Jones A., Wilkens L.R., Le Marchand L. CYP1A1, GSTM1, and GSTP1 genetic polymorphisms and urinary 1-hydroxypyrene excretion in non-occupationally exposed individuals. Cancer Epidemiol. Biomarkers Prev. 9:2000;1119-1122.
15. Pelkonen O., Maenpaa J., Taavitsainen P., Rautio A., Raunio H. Inhibition and induction of human cytochrome P450 (CYP) enzymes. Xenobiotica. 28:1998;1203-1253.
16. Rendic S., Di Carlo F.J. Human cytochrome P450 enzymes. a status report summarizing their reactions, substrates, inducers, and inhibitors Drug Metab. Rev. 29:1997;413-580.
17. Shimada T., Yamazaki H., Mimura M., Inui Y., Guengerich F.P. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals. Studies with liver microsomes of 30 Japanese and 30 caucasians J. Pharmacol. Exp. Ther. 270:1994;414-423.
18. Shimada T., Hayes C.L., Yamazaki H., Amin S., Hecht S.S., Guengerich F.P., Sutter T.R. Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Res. 56:1996;2979-2984.
19. Shimada T., Oda Y., Gillam E.M., Guengerich F.P., Inoue K. Metabolic activation of polycyclic aromatic hydrocarbons and other procarcinogens by cytochromes P450 1A1 and P450 1B1 allelic variants and other human cytochromes P450 in Salmonella typhimurium NM2009. Drug Metab. Dispos. 29:2001;1176-1182.
20. Shimada T., Inoue K., Suzuki Y., Kawai T., Azuma E., Nakajima T., Shindo M., Kurose K., Sugie A., Yamagishi Y., Fujii-Kuriyama Y., Hashimoto M. Arylhydrocarbon receptor-dependent induction of liver and lung cytochromes P450 1A1, 1A2, and 1B1 by polycyclic aromatic hydrocarbons and polychlorinated biphenyls in genetically engineered C57BL/6J mice. Carcinogenesis. 23:2002;1199-1207.
21. Taguchi T., Horike T., Ogata M. Micro determination of urinary 1-pyrenol by high performance liquid chromatography. Med. Bio. 127:1993;201-205.
22. Watanabe J., Shimada T., Gillam E.M., Ikuta T., Suemasu K., Higashi Y., Gotoh O., Kawajiri K. Association of CYP1B1 genetic polymorphism with incidence to breast and lung cancer. Pharmacogenetics. 10:2000;25-33.
23. Wu M.T., Huang S.L., Ho C.K., Yeh Y.F., Christiani D.C. Cytochrome P450 1A1 MspI polymorphism and urinary 1-hydroxypyrene concentrations in coke-oven workers. Cancer Epidemiol. Biomarkers Prev. 7:1998;823-829.